Vitrolife: Interim Report January-March 2014: Strengthened Operating Margin

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Vitrolife AB (STO:VITR):

· Sales growth was 12 percent in local currency. Sales amounted to SEK 119 (105) million, corresponding to an increase of 14 percent in SEK.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC